Equillium, Inc. (EQ): Price and Financial Metrics
GET POWR RATINGS... FREE!
EQ Stock Price Chart Interactive Chart >
EQ Price/Volume Stats
|Current price||$1.08||52-week high||$4.38|
|Prev. close||$1.00||52-week low||$0.79|
|Day high||$1.09||Avg. volume||75,527|
|50-day MA||$1.25||Dividend yield||N/A|
|200-day MA||$2.01||Market Cap||37.17M|
Equillium, Inc. (EQ) Company Bio
Equillium Inc. is leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company is based in La Jolla, California.
Most Popular Stories View All
EQ Latest News Stream
|Loading, please wait...|
EQ Latest Social Stream
View Full EQ Social Stream
Latest EQ News From Around the Web
Below are the latest news stories about EQUILLIUM INC that investors may wish to consider to help them evaluate EQ as an investment opportunity.
Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
LA JOLLA, Calif., January 13, 2023--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that an abstract was accepted for oral presentation at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy, and the Center for International Blood & Marrow Transplant Research. The Hybrid meetings will take place virtually
Equillium Inc. (NASDAQ: EQ) Is Down -36.14% In A Month. Could There Be Any Hope That It Will Rise Soon?
During the last session, Equillium Inc. (NASDAQ:EQ)’s traded shares were 0.32 million, with the beta value of the company hitting 1.27. At the end of the trading day, the stock’s price was $1.06, reflecting an intraday gain of 20.45% or $0.18. The 52-week high for the EQ share is $4.38, that puts it down -313.21 … Equillium Inc. (NASDAQ: EQ) Is Down -36.14% In A Month. Could There Be Any Hope That It Will Rise Soon? Read More »
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Metacrine, Inc. (NASDAQ: MTCR ) and Equillium, Inc. (NASDAQ: EQ ) mutually agreed to terminate definitive merger agreement. Metacrine shares jumped 5.4% to $0.4551 in after-hours trading, while Equillium shares dropped 6.3% to close … Full story available on Benzinga.com
Equillium, Inc. (Nasdaq: EQ) and Metacrine, Inc. today announced the mutual termination of their previously announced definitive merger agreement. “Eq
LA JOLLA, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.
EQ Price Returns